What study patients received
Thymosin Alpha-1 Dosage Varied by Illness
Study teams chose an amount for each group. Those amounts aren't directions for your care.
Studies used a small shot under the skin
Studies gave the drug by a small shot into the fat below your skin. This page lists Thymosin Alpha-1 dosage facts, not your treatment plan.
Approved liver care abroad used 1.6 mg on two days each week. Sepsis and COVID-19 studies left shorter gaps between shots.
About two hours after the blood level peaked, the blood held half that highest amount. That fast fall helps explain why studies used more than one shot.
These amounts describe research, not personal care. The effects page explains who may face more risk.
Thymosin alpha 1 dosage depended on the illness
Thymosin Alpha-1 amounts changed with the illness under study. One review found single shots of 0.8–6.4 mg; repeat-shot courses totaled 1.6–16 mg during a full course lasting five to seven days [4].
Long-term hepatitis care injected 1.6 mg beneath the skin twice weekly. In two sepsis tests, patients received 1.6 mg every 12 hours for five to seven days [2][3].
COVID-19 reports used a daily 1.6 mg shot under the skin [6]. These were set research plans and won't fit every person.
A Thymosin alpha 1 injection went into body fat
Almost every study put the Thymosin alpha 1 injection into fat under the skin. The needle did not go into a vein or muscle.
Study staff received the drug as dry powder. They mixed it with clean, germ-free liquid before each shot [4].
The body clears the drug fast, so studies used repeat shots. A mild sore or red patch was the most common trouble [15].
Blood levels fell quickly after the peak
The blood level peaked within the first one to two hours after a shot. Two hours later, the blood held half that peak amount; by 24 hours, it was near the level before the shot [4].
The drug also left the blood and entered fluid surrounding the body's cells. That travel fact can't tell you whether a patient improved.
New work seeks a shot that releases the drug for up to two weeks [17]. A slower release wouldn't prove a longer health benefit.
Study amounts don't set your dose
Clinics and research teams chose the amounts listed above. Those figures don't support using an unchecked vial on your own.
The fairest test in deadly sepsis found no gain in survival [3]. A dose used in research can't promise a benefit.
The figures only record what study patients received. Your own doctor can weigh the drug against your health.